Letter: Colorectal Cancer Risk After Faecal Immunochemical Testing—Which Risk Should Guide Referral? Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-11-17
DOI: 10.1111/apt.71097 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-11-17. Written by Francesca Ligori Malcolm and 3 co-authors. Institution: Colorectal Service, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK. 7 references. Funded by: National Institute for Health and Care Research.
Abstract (original language)
Abstract non disponibile.
Subjects
Author keywords
Authors and institutions
- Colorectal Service, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK.
- School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
- Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.
- Department of Clinical Medicine-Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N, Denmark.
ORCID profiles: Francesca Ligori Malcolm, Colin J Crooks, Joe West, David J Humes
Funding
- National Institute for Health and Care Research
Cite
APA
Malcolm, F. L., Crooks, C. J., West, J., & Humes, D. J. (2026). Letter: Colorectal Cancer Risk After Faecal Immunochemical Testing—Which Risk Should Guide Referral? Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71097
Vancouver
Malcolm FL, Crooks CJ, West J, Humes DJ. Letter: Colorectal Cancer Risk After Faecal Immunochemical Testing—Which Risk Should Guide Referral? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71097
BibTeX
@article{Malcolm2026,
author = {Malcolm, Francesca Ligori and Crooks, Colin J and West, Joe and Humes, David J},
title = {Letter: Colorectal Cancer Risk After Faecal Immunochemical Testing—Which Risk Should Guide Referral? Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71097}
}
EUVIMED